Received Oct 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
suffered similar side-effects/diagnosed it as "Vasculitis"; This is a spontaneous report received from a Consumer or other non HCP. An adult male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose number 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VASCULITIS (non-serious), outcome "recovering", described as "suffered similar side-effects/diagnosed it as "Vasculitis"". Relevant laboratory tests and procedures are available in the appropriate section. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received. Additional Information: The patient in his 40's suffered side-effects from the Pfizer vaccine and his doctor diagnosed it as "Vasculitis'. His recovery was swifter. The doctor discovered that his Anti-Body level was extremely high, which meant, receiving the Covid 19 vaccine created more unnecessary Anti-Bodies which the immune system saw as more of an attack, and the response was major inflammation.
Test Name: Anti-Body level; Result Unstructured Data: Test Result:extremely high